Mitchell Browne
YOU?
Author Swipe
View article: 2280. Surveillance of Life-Long Antibiotics (SOLLA) 2: Patients on Life-Long Antibiotics in an Australian Healthcare Network
2280. Surveillance of Life-Long Antibiotics (SOLLA) 2: Patients on Life-Long Antibiotics in an Australian Healthcare Network Open
Background There is a range of conditions for which long-term antibiotics are prescribed, most of which lack high quality evidence. Apart from promoting antimicrobial resistance, long-term antibiotics also impact the individual patient, di…
View article: 18 Monash status epilepticus study (MOSES): glasgow coma score, age and inpatient onset, not time to treatment, predict mortality in status epilepticus
18 Monash status epilepticus study (MOSES): glasgow coma score, age and inpatient onset, not time to treatment, predict mortality in status epilepticus Open
Background There is ongoing controversy over the predictors of mortality and morbidity in status epilepticus (SE). As a result, many of the mortality prediction tools that have been introduced have failed to gain widespread acceptance. Obj…
View article: 2267 The Monash Status Epilepticus Study (MOSES) – Age, initial GCS and inpatient onset, not time to treatment, is associated with in-hospital mortality and morbidity
2267 The Monash Status Epilepticus Study (MOSES) – Age, initial GCS and inpatient onset, not time to treatment, is associated with in-hospital mortality and morbidity Open
Objectives Status epilepticus (SE) is a medical emergency with high mortality and morbidity. We aimed to determine the predictors of in-hospital mortality and increased disability in an Australian setting. Methods We retrospectively review…
View article: COVID‐19 VACCINE RESPONSE IN PATIENTS ON CANCER THERAPY ‐ EVIDENCE FROM AUSTRALIAN DATA
COVID‐19 VACCINE RESPONSE IN PATIENTS ON CANCER THERAPY ‐ EVIDENCE FROM AUSTRALIAN DATA Open
systemic and microglia inflammation as described in ME/CFS.The clinical manifestation in the present case was worsening in the symptoms of the ME/CFS.The patient was already on Spironolactone targeting the increase on number of macrophages…